Deva Holding A.S. (IST:DEVA)

Market Cap	15.02B +0.7%
Revenue (ttm)	14.59B -25.8%
Net Income	300.30M -93.7%
EPS	1.50 -93.7%
Shares Out	200.02M
PE Ratio	50.02
Forward PE	n/a
Dividend	0.29 (0.39%)
Ex-Dividend Date	n/a

Volume	1,342,696
Average Volume	849,047
Open	75.25
Previous Close	75.10
Day's Range	73.75 - 76.00
52-Week Range	51.00 - 75.65
Beta	-0.50
RSI	79.55
Earnings Date	Mar 6, 2026

About Deva Holding A.S.

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary syste...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1958
• Employees: 3,036
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: DEVA

Financial Performance

In 2024, Deva Holding A.S.'s revenue was 15.46 billion, a decrease of -5.50% compared to the previous year's 16.36 billion. Earnings were 69.42 million, a decrease of -98.58%.